Syncona ups value of Freeline Therapeutics investment after fundraise
Healthcare investor Syncona said portfolio company Freeline Therapeutics had raised $80m from institutional investors.
Freeline Therapeutics was focused on developing curative gene therapies for chronic...
Tue, 30/06/2020 - 07:59